Experimental and clinical aspects of the pathogenesis of endotoxin shock

Abstract

The occurrence of a shock-like state in connection with an infectious disease was first reported by Laennek in 1831. More specifically, this relationship was established in 1899 [46]. The absence of a noticeable decrease in the frequency of recorded endotoxin shock in humans is due to a number of factors, the most important among which are the following: a) improvement in the diagnosis of endotoxin shock, made possible by the use of sophisticated diagnostic equipment; b) familiarity of specialists of various profiles with this nosological form; c) an increase in the life expectancy of patients with severe pathology and a decrease in general and immunological reactivity; d) the use of immunosuppressants and cytostatic drugs for allergies, malignant neoplasms, which facilitates the development of infectious pathology; e) frequent obstetric pathology, accompanied by the birth of children with reduced resistance; f) widespread use of antibiotic therapy, leading to the emergence of antibiotic-resistant microbes; it should also be noted here that when treating septic foci and infectious diseases with antibiotics, there is a danger of massive entry into the bloodstream of endotoxins released from dead microorganisms; g) carrying out complex diagnostic manipulations and surgical operations that open the entrance gates for infection.

Keywords

Kazan Medical archive

References

[1] Иванов И. Р., Шенкман Б. 3. а) Журн. микробиол., эпидемиол. и иммунобиол., 1979, 6; б) Казанский мед. ж., 1981, 2; в) Журн. микробиол., эпидемиол. и иммунобиол., 1981, 9.

[2] Каньшина Н. Ф. Арх. патол., 1976, 11.

[3] Лыткин М. И., Костин Э’. Д., Косюченко А. Л., Терешин И. М. Септический шок. Л., Медицина, 1980.

[4] Пак С. Г., Турьянов М. X., Казанская Л. В., Бобылев Р. В. Тер. арх., 1981, 10.

[5] Аdе1еуе G. А., Furman В. L., Раггаtt J. R. Brit. J. Pharmacol., 1982, 76, Suopl.

[6] Alican E., Dalton M. L. Jr., Hardy J. D. Amer. J. Surg., 1962, 103, 702,

[7] Berry L. I., Rippe D. F. J. Infect. Diseases, 1973, 128, Suppl.

[8] Bohn E., Müller B. G. Amer. J. Pathol., 1976, 84, 239.

[9] Bo1e11i M., Cadrobbi P., Andino G.,. Valenti F. G. mal. infett. e. parassit., 1973, 25, 569.

[10] Bradley S. G. Ann. Rev. Microbiol., 1979, 33, 67.

[11] BiIt H., Heitman A. G. Agents and Actions, 1979, 9, 650.

[12] Butler R. R., Wise W. C. Ha1ushka P. V., Gооk J. A. Cire. Shock., 1981, 8, 213.

[13] Chedid L., Skarns R. C., Parant M. J. exp. Med., 1961, 117, 561.

[14] Cook J. A., Wise W. C., Halushka R. V. J. clin. Invest., 1980, 65, 227,

[15] Da Vis R. B., Meeker W. R., Mc Guaprie D. G. Circulât. Res., 1960, 8, 234.

[16] Demling R. H., Smi-th M. a. o. Amer. J. Physiol., 1981, 240, 4348,

[17] DesPrez R. M., Horoivitz H. J., Hook E. W. J. exp. Med., 1961, 114, 857,

[18] Engle R. L., Rink R. D. J. Surg. Res, 1976, 21, 7,

[19] Filkins J P, Buchanan B. J. Proc. Soc. Exp. Biol. and Med., 1977, 155, 216.

[20] Gilbert V. E., Braude A. I. J. exp. Med, 1962, 116, 477.

[21] Giron G. P. Minerva Anesthesiol., 1980, 46, 1057.

[22] Ha1es C. A., Sоnne L. a. o. J. clin. Invest. 1981, 68 497.

[23] Hawiger J., Hawiger A., Timmons S., Nature, 1975, 256, 125.

[24] Herring W. B., Heriоn J. C., Walker K. L, Pa1mer J. G. J. clin. Invest, 1963 42 79.

[25] Hierro F. R., Palomegue A., Calvo M., Torraba A. Paediatrician, 1979, 8, 93.

[26] Hiller E., Saal J. G., Griffits E. WA Blut, 1977, 34, 409.

[27] Hinshaw L. B. Cire. Shock, 1979, Suppl., 1.

[28] Hinshaw L. B., Archer L. T. a. o. Amer. J. Physiol., 1974, 226, 357.

[29] HorowitzH. I. Des PrezR. M., Hook E. W. J. exp. Med., 1962, 116, 619.—

RIGHTS & PERMISSIONS

Eco-Vector